Who owns ASCENDIS PHARMA A/S?
- CUSIP Number: 04351pad3
Tip: Access positions for across all investors
Analyze quarterly positions in Ascendis Pharma A/s with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ascendis Pharma A/s stock
Who bought or sold ASCENDIS PHARMA A/S this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 169M | $187M | 100% | Dec 2024 |
|
| Wolverine Asset Management | 76M | $83M | -11% | Dec 2024 |
|
| Franklin Resources | 48M | $53M | 0% | Dec 2024 |
|
| Lazard Asset Management | 35M | $39M | 144% | Dec 2024 |
|
| Point72 Asset Management | 32M | $35M | 85% | Dec 2024 |
|
| Readystate Asset Management | 31M | $36M | -26% | Sep 2024 |
|
| Davidson Kempner Capital Management | 30M | $33M | 9% | Dec 2024 |
|
| Partner Fund Management | 23M | $25M | 0% | Dec 2024 |
|
| Zazove Associates | 15M | $17M | 17% | Dec 2024 |
|
| Oaktree Capital Management | 15M | $16M | 17% | Dec 2024 |
|
| State Street Corporation | 14M | $15M | 8% | Dec 2024 |
|
| Polar Capital Holdings | 13M | $15M | 31% | Sep 2024 |
|
| SSI Investment Management | 10M | $11M | -3% | Dec 2024 |
|
| Millennium Management | 10M | $11M | 0% | Dec 2024 |
|
| BlackRock | 6.1M | $6.7M | 21% | Dec 2024 |
|
| Ameriprise Financial | 5.9M | $6.5M | 100% | Dec 2024 |
|
| Morgan Stanley | 5.4M | $5.9M | 0% | Dec 2024 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 5.0M | $5.5M | -58% | Dec 2024 |
|
| Nicholas Investments Partners | 4.3M | $4.7M | 0% | Dec 2024 |
|
| DAFNA Capital Management | 4.0M | $4.4M | 0% | Dec 2024 |
|
| Shenkman Capital Management | 3.7M | $4.3B | 521% | Dec 2024 |
|
| CSS | 3.5M | $3.9M | 75% | Dec 2024 |
|
| Royal Bank of Canada | 3.0M | $3.3M | -20% | Dec 2024 |
|
| Barclays | 2.7M | $3.0M | 70% | Dec 2024 |
|
| RWC Asset Management | 2.7M | $3.0M | 8% | Dec 2024 |
|
| Citigroup | 2.3M | $2.6M | 97% | Dec 2024 |
|
| Bnp Paribas Investment Partners | 2.0M | $2.2M | 0% | Dec 2024 |
|
| Man Group | 1.7M | $1.9M | 0% | Dec 2024 |
|
| Ubs Global Asset Management Americas | 1.5M | $1.6M | -32% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.3M | $1.4M | 61% | Dec 2024 |
|
| Jane Street | 1.2M | $1.3M | 100% | Dec 2024 |
|
| Ing Investment Management | 1.1M | $1.2M | 228% | Dec 2024 |
|
| Wells Fargo & Company | 574k | $632k | 4% | Dec 2024 |
|
| Central Pacific Bank - Trust Division | 530k | $582k | 0% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 375k | $412k | 100% | Dec 2024 |
|
| Russell Investments | 372k | $413k | 131% | Dec 2024 |
|
| KBC Group NV | 200k | $221k | 0% | Dec 2024 |
|
| First Hawaiian Bank | 161k | $177k | 0% | Dec 2024 |
|
| Oaktree Fund Advisors | 24k | $28k | 41% | Sep 2024 |
|
Who sold out of Ascendis Pharma A/s?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Advent Capital Management | Sep 2024 | 7.5M | $8.8M |
| Bank of America Corporation | Sep 2024 | 6.0M | $6.9M |
| Lombard Odier Asset Management | Sep 2024 | 5.4M | $6.3M |
| Susquehanna International | Sep 2024 | 2.5M | $2.9M |
| Agf Management | Sep 2024 | 1.0M | $1.2M |